This article has been updated with additional information from the FDA regarding the scope of the proposed premarket notification exemptions. 

NEW YORK (GenomeWeb) – The US Food and Drug Administration has identified more than 1,000 Class II devices that it plans to exempt from 510(k) premarket notification requirements, including a number of genomic analysis instruments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.